Your browser doesn't support javascript.
loading
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial.
Andrieux-Meyer, Isabelle; Tan, Soek-Siam; Thanprasertsuk, Sombat; Salvadori, Nicolas; Menétrey, Caroline; Simon, François; Cressey, Tim R; Said, Hajjah Rosaida Hj Mohd; Hassan, Muhammad Radzi Abu; Omar, Haniza; Tee, Hoi-Poh; Chan, Wah Kheong; Kumar, Suresh; Thongsawat, Satawat; Thetket, Kanawee; Avihingsanon, Anchalee; Khemnark, Suparat; Yerly, Sabine; Ngo-Giang-Huong, Nicole; Siva, Sasikala; Swanson, Alistair; Goyal, Vishal; Bompart, Francois; Pécoul, Bernard; Murad, Shahnaz.
Afiliação
  • Andrieux-Meyer I; Drugs for Neglected Diseases initiative, Geneva, Switzerland. Electronic address: Switzerlandiandrieux-meyer@dndi.org.
  • Tan SS; Department of Hepatology, Selayang Hospital, Batu Caves, Malaysia.
  • Thanprasertsuk S; Department of Disease Control, Ministry of Public Health, Bangkok, Thailand.
  • Salvadori N; Public Health Promotion Research and Training-Institut de Recherche pour le Développement, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Menétrey C; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Simon F; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Cressey TR; Public Health Promotion Research and Training-Institut de Recherche pour le Développement, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Said HRHM; Gastroenterology & Hepatology Unit, Ampang Hospital, Ampang Jaya, Malaysia.
  • Hassan MRA; Gastroenterology Unit, Medical Department, Hospital Sultanah Bahiyah, Alor Setar, Malaysia.
  • Omar H; Department of Hepatology, Selayang Hospital, Batu Caves, Malaysia.
  • Tee HP; Gastroenterology Unit, Medical Department, Hospital Tengku Ampuan Afzan, Kuantan, Malaysia.
  • Chan WK; Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Kumar S; Infectious Disease Unit, Medical Department, Hospital Sungai Buloh, Selangor, Malaysia.
  • Thongsawat S; Department of Internal Medicine, Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand.
  • Thetket K; Internal Medicine unit, Medical Department, Nakornping Hospital, Chiang Mai, Thailand.
  • Avihingsanon A; HIV-Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; Tuberculosis Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Khemnark S; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand.
  • Yerly S; Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland.
  • Ngo-Giang-Huong N; Public Health Promotion Research and Training-Institut de Recherche pour le Développement, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; Laboratory of Virology, Program for HIV Prevention and Treatment L'Institut de Recherche pour le Développement, Chiang Mai,
  • Siva S; Drugs for Neglected Diseases initiative, Kuala Lumpur, Malaysia.
  • Swanson A; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Goyal V; Drugs for Neglected Diseases initiative, New York, NY, USA.
  • Bompart F; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Pécoul B; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Murad S; Ministry of Health, Kuala Lumpur, Malaysia.
Lancet Gastroenterol Hepatol ; 6(6): 448-458, 2021 06.
Article em En | MEDLINE | ID: mdl-33865507
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Valina / Benzimidazóis / Proteínas não Estruturais Virais / Hepatite C Crônica / Sofosbuvir Tipo de estudo: Clinical_trials / Etiology_studies País/Região como assunto: Asia Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Valina / Benzimidazóis / Proteínas não Estruturais Virais / Hepatite C Crônica / Sofosbuvir Tipo de estudo: Clinical_trials / Etiology_studies País/Região como assunto: Asia Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article